Longer Failure-Free Survival Interval of Epstein-Barr Virus–Associated Classical Hodgkin’s Lymphoma: A Single-Institution Study
Jens Krugmann, Alexandar Tzankov, Andreas Gschwendtner, Martina Fischhofer, Richard Greil, Falko Fend, Stephan Dirnhofer
Abstract
Open-access reader